Towner D R, Shaffer L G, Yang S P, Walgenbach D D
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine and Pediatrics, University of California Davis, Sacramento, CA 95817, USA.
Prenat Diagn. 2001 May;21(5):395-8. doi: 10.1002/pd.75.
A case of confined placental mosaicism (CPM) and maternal uniparental isodisomy 14 identified after placental karyotype revealed trisomy 14 in a newborn with intrauterine growth restriction (IUGR) and minor dysmorphic features is reported. During the second trimester of the pregnancy, multiple marker screening revealed an increased risk for Down syndrome of > 1 in 10. The maternal serum human chorionic gonadotrophin (MShCG) was markedly elevated at 4.19 MoM. Amniocentesis revealed a normal 46,XX karyotype. Fetal growth restriction has been associated with elevated MShCG and placental aneuploidy with CPM for chromosomes 2, 7, 9 and 16. The present case of CPM for chromosome 14 was also associated with fetal growth restriction and elevated second trimester MShCG, suggesting a common link. Further studies need to be done to determine if indeed elevation of second trimester MShCG is associated with increased risk of CPM. The present case again demonstrates the need to perform placental karyotype in unexplained fetal growth restriction.
本文报告了一例局限性胎盘嵌合体(CPM)及母亲单亲二体14,该病例是在一名患有宫内生长受限(IUGR)和轻微畸形特征的新生儿胎盘核型显示14三体后被发现的。在妊娠中期,多项标志物筛查显示唐氏综合征风险增加,大于1/10。孕妇血清人绒毛膜促性腺激素(MShCG)显著升高,为4.19倍中位数(MoM)。羊水穿刺显示核型正常,为46,XX。胎儿生长受限与MShCG升高以及2、7、9和16号染色体CPM导致的胎盘非整倍体有关。本例14号染色体CPM也与胎儿生长受限及妊娠中期MShCG升高有关,提示存在共同联系。需要进一步研究以确定妊娠中期MShCG升高是否确实与CPM风险增加有关。本病例再次表明,对于不明原因的胎儿生长受限,有必要进行胎盘核型分析。